Psoriasis beyond the skin: systemic inflammation as a bridge to metabolic and hepatic comorbidities

Key Points

• Systemic inflammation significantly correlates with metabolic comorbidities in psoriasis patients, highlighting a broader health impact.
• Patients with psoriasis often experience not only skin symptoms but also increased risk for metabolic conditions and liver issues.
• Analysis of patient health records across several clinics indicates a strong connection between immune responses and comorbidities.
• Understanding the link between systemic inflammation and these conditions may improve treatment approaches and patient outcomes.